V CompBrief BY VELARION

Chief Medical Officer · GALECTIN THERAPEUTICS INC (GALT)

Khurram Jamil, M.D.

FY2024 is the first fiscal year CompBrief holds for Khurram Jamil, M.D. as a named executive officer of GALECTIN THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2024

$945,847

2nd of 3 named executive officers at Galectin Therapeutics by FY2024 total.

3 named officers on file for GALECTIN THERAPEUTICS, FY2024

See an example →

What this number hides

The filing gives the total. GALECTIN THERAPEUTICS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how GALECTIN THERAPEUTICS’s whole pay program stands against its peers

  • GALECTIN THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GALT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 22, 2025 (DEF 14A).

Free

Get Khurram Jamil, M.D.’s full pay file as a PDF — free

More than this page: up to 10 years of Khurram’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Khurram Jamil, M.D. and every company like it: Velarion Intel, free for 3 days, no card →

Khurram Jamil, M.D. compensation by year

GALECTIN THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as GALECTIN THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$365,909
Bonus$120,625
Stock awards$398,500
All other$60,813
Total$945,847

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GALECTIN THERAPEUTICS INC DEF 14A filed October 22, 2025, accession 0001140361-25-038875, and prior-year filings.

How this page was built: the GALECTIN THERAPEUTICS INC filed document, accession 0001140361-25-038875. Every figure is read from that document and cited to the page and table it appears in. Filed October 22, 2025.

GALECTIN THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Joel LewisChief Executive Officer & President$1,189,674
Khurram Jamil, M.D. · this pageChief Medical Officer$945,847
Jack CallicuttChief Financial Officer$716,945

Khurram Jamil, M.D.'s compensation dossier, GALECTIN THERAPEUTICS

You have read Khurram Jamil, M.D.'s totals and holdings. The dossier adds each equity grant GALECTIN THERAPEUTICS disclosed for Khurram Jamil, M.D. and GALECTIN THERAPEUTICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full GALECTIN THERAPEUTICS compensation record

free company brief
GALECTIN THERAPEUTICS INC (GALT) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within GALECTIN THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order GALECTIN THERAPEUTICS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GALECTIN THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Khurram Jamil, M.D.'s compensation dossier